Updated: December 22, 2023
1
Filter
Overview
- As per Volza’s Peru Import data, Lopinavir import shipments in Peru stood at 532, imported by 18 Peru Importers from 20 Suppliers.
- Peru imports most of its Lopinavir from India, United States and Brazil and is the 3rd largest importer of Lopinavir in the World.
- The top 3 importers of Lopinavir are Brazil with 1,267 shipments followed by Uganda with 612 and Peru at the 3rd spot with 532 shipments.
- Top 3 Product Categories of Lopinavir Imports in Peru are
These facts are updated till 22 Dec 2023, and are based on Volza's Peru Import dataPeru Import data of Lopinavir sourced from 70 countries export import shipments with names of buyers, suppliers, top Decision maker's contact information like Direct, phone, email and LinkedIn profiles.
Lopinavir import data of Peru - 532 import shipments
All Filters
Applied Filters
PeruX
Top HSN Code
By Shipments
By Name
Top Exporting Countries
By Shipments
By Name
India
(457)United States
(38)Brazil
(21)Germany
(12)United Kingdom
(2)China
(1)United Arab Emirates
(1)View More (7)
Top Importing Countries
By Shipments
By Name
Myanmar
(252)Thailand
(249)Congo
(219)Singapore
(218)United Arab Emirates
(178)Nigeria
(159)United States
(152)Vietnam
(128)Cameroon
(124)Chile
(120)Belgium
(119)Colombia
(115)Iran
(112)France
(105)Ecuador
(102)Mozambique
(98)Zimbabwe
(94)Guatemala
(93)Lesotho
(93)Indonesia
(92)Russia
(92)Tanzania
(92)Ethiopia
(86)Paraguay
(85)Malawi
(84)Bolivia
(78)Ghana
(75)Senegal
(75)China
(71)Namibia
(68)Haiti
(67)Ukraine
(64)Swaziland
(63)Mali
(61)Algeria
(58)Cambodia
(58)Ivory Coast
(57)Uzbekistan
(56)Oman
(55)Togo
(55)Mexico
(54)Denmark
(53)Honduras
(52)Bahamas
(51)Burkina Faso
(51)Dominican Republic
(49)Bangladesh
(48)Guinea
(48)Philippines
(48)Pakistan
(47)Angola
(46)United Kingdom
(46)Vanuatu
(46)Benin
(45)Jamaica
(45)Papua New Guinea
(44)Sudan
(44)Central African Republic
(43)Sri Lanka
(42)Uruguay
(42)Zambia
(41)Venezuela
(39)Bahrain
(38)Nepal
(37)Argentina
(35)Ireland
(35)Rwanda
(34)Cuba
(33)Guinea Bissau
(33)Turkey
(33)Burundi
(32)Libya
(32)Yemen
(32)Botswana
(30)Panama
(30)Nicaragua
(29)Saudi Arabia
(29)Gabon
(27)Iraq
(27)Italy
(27)Lebanon
(27)Trinidad and Tobago
(26)Chad
(25)Mauritius
(24)Sierra Leone
(24)Costa Rica
(22)Tunisia
(22)Australia
(21)Croatia
(21)Malta
(21)Niger
(21)Guyana
(20)Hong Kong
(20)Morocco
(20)Somalia
(20)Azerbaijan
(19)Djibouti
(19)Fiji
(19)Jordan
(19)Laos
(19)Egypt
(18)Mauritania
(18)Kyrgyzstan
(17)Eritrea
(16)Gambia
(16)Saint Kitts And Nevis
(16)East Timor
(15)Equatorial Guinea
(15)Madagascar
(15)Germany
(14)Liberia
(14)Suriname
(14)Tajikistan
(14)Afghanistan
(13)Belarus
(13)Dominica
(13)Grenada
(13)Israel
(13)Saint Lucia
(13)Barbados
(12)Syria
(12)Bhutan
(11)British Virgin Islands
(11)Serbia And Montenegro
(11)Belize
(10)Canada
(10)Mongolia
(10)Spain
(10)Anguilla
(8)Bermuda
(8)Portugal
(8)Cape Verde Islands
(7)El Salvador
(7)Antigua and Barbuda
(6)New Zealand
(6)Switzerland
(6)Taiwan
(6)Austria
(5)Comoros
(5)Georgia
(5)Turks and Caicos Islands
(5)Albania
(4)Armenia
(4)Lithuania
(4)Poland
(4)Seychelles
(4)Turkmenistan
(4)Macedonia
(3)Malaysia
(3)Maldives
(3)Moldova
(3)Qatar
(3)Sao Tome And Principe
(3)Curacao
(2)Greece
(2)Japan
(2)Kazakhstan
(2)Kuwait
(2)Palestine
(2)Cyprus
(1)Latvia
(1)Slovenia
(1)View More (169)
Top Related HSN Code
By Shipments
By Name
2933
(20)2922
(18)2934
(17)2941
(11)3002
(9)3004
(8)Top Related Products
By Shipments
By Name
View More (20)
Export Data by Country
By Shipments
By Name
United Kingdom
(94)Finland
(92)Canada
(74)Argentina
(70)Uruguay
(41)China
(34)Italy
(33)Belgium
(29)Turkey
(24)Poland
(21)Greece
(11)Ireland
(11)Japan
(8)South Africa
(8)Indonesia
(7)Spain
(7)Sweden
(6)Peru
(5)Cyprus
(4)Vietnam
(4)Mexico
(3)Singapore
(3)Israel
(2)Netherlands
(2)Australia
(1)Chile
(1)Dominican Republic
(1)Ecuador
(1)Kenya
(1)Malaysia
(1)Namibia
(1)Oman
(1)Puerto Rico
(1)United Arab Emirates
(1)View More (40)
Top Buyer Countries
By Shipments
By Name
Congo
(41)Netherlands
(40)India
(39)United States
(36)Uganda
(32)United Arab Emirates
(32)Myanmar
(29)Iran
(26)South Africa
(25)Kenya
(24)Singapore
(24)Ecuador
(23)Russia
(23)Nigeria
(21)Chile
(19)Peru
(18)Brazil
(17)Guinea
(17)Ghana
(16)Mexico
(16)Pakistan
(16)Belgium
(15)Tanzania
(15)United Kingdom
(15)Iraq
(15)Zimbabwe
(14)Guatemala
(14)Oman
(14)Malawi
(13)Mali
(13)Ivory Coast
(13)Nicaragua
(13)Saudi Arabia
(13)France
(12)Indonesia
(12)Namibia
(12)Burkina Faso
(12)Benin
(12)Sri Lanka
(12)Zambia
(12)Turkey
(12)Cameroon
(11)Colombia
(11)Ethiopia
(11)Haiti
(11)Ukraine
(11)Swaziland
(11)Venezuela
(11)Libya
(11)Dominican Republic
(10)Bangladesh
(10)Philippines
(10)Nepal
(10)Rwanda
(10)Mauritius
(10)Jordan
(10)Mozambique
(9)Bolivia
(9)Senegal
(9)China
(9)Togo
(9)Jamaica
(9)Botswana
(9)Italy
(9)Trinidad and Tobago
(9)Chad
(9)Somalia
(9)Angola
(8)Sudan
(8)Australia
(8)Morocco
(8)Azerbaijan
(8)Djibouti
(8)Fiji
(8)Saint Kitts And Nevis
(8)Germany
(8)Lesotho
(7)Paraguay
(7)Cambodia
(7)Uzbekistan
(7)Honduras
(7)Cuba
(7)Burundi
(7)Lebanon
(7)Costa Rica
(7)Egypt
(7)Mauritania
(7)Belarus
(7)Saint Lucia
(7)Bhutan
(7)Bahamas
(6)Yemen
(6)Sierra Leone
(6)Hong Kong
(6)Equatorial Guinea
(6)Liberia
(6)Grenada
(6)Thailand
(5)Denmark
(5)Central African Republic
(5)Panama
(5)Malta
(5)Niger
(5)Eritrea
(5)Barbados
(5)British Virgin Islands
(5)El Salvador
(5)Taiwan
(5)Papua New Guinea
(4)Bahrain
(4)Guinea Bissau
(4)Tunisia
(4)Guyana
(4)Kyrgyzstan
(4)East Timor
(4)Afghanistan
(4)Dominica
(4)Israel
(4)Canada
(4)Spain
(4)Portugal
(4)Switzerland
(4)Austria
(4)Algeria
(3)Vanuatu
(3)Uruguay
(3)Argentina
(3)Gabon
(3)Croatia
(3)Laos
(3)Gambia
(3)Madagascar
(3)Suriname
(3)Tajikistan
(3)Syria
(3)Belize
(3)Mongolia
(3)Anguilla
(3)Antigua and Barbuda
(3)Poland
(3)Seychelles
(3)Malaysia
(3)Moldova
(3)Serbia And Montenegro
(2)Bermuda
(2)Cape Verde Islands
(2)New Zealand
(2)Comoros
(2)Georgia
(2)Turks and Caicos Islands
(2)Albania
(2)Armenia
(2)Lithuania
(2)Maldives
(2)Qatar
(2)Sao Tome And Principe
(2)Japan
(2)Kazakhstan
(2)Ireland
(1)Turkmenistan
(1)Macedonia
(1)Curacao
(1)Greece
(1)Kuwait
(1)Palestine
(1)Latvia
(1)Cyprus
(0)Slovenia
(0)View More (169)
Top Supplier Countries
By Shipments
By Name
United States
(30)Germany
(21)China
(16)France
(11)United Kingdom
(7)Canada
(4)South Africa
(4)Belgium
(3)Turkey
(3)Mexico
(3)Brazil
(2)Argentina
(2)Indonesia
(2)Peru
(2)Vietnam
(2)Netherlands
(2)Italy
(1)Japan
(1)Spain
(1)Singapore
(1)Chile
(1)Dominican Republic
(1)Ecuador
(1)Kenya
(1)Malaysia
(1)Namibia
(1)Oman
(1)Switzerland
(0)Finland
(0)Uruguay
(0)Poland
(0)Greece
(0)Ireland
(0)Sweden
(0)Cyprus
(0)Israel
(0)Australia
(0)Puerto Rico
(0)United Arab Emirates
(0)View More (40)
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
|---|
| 3004902400 | LOPINAVIR 200 MG + RITONAVIR 50 MG,S/M,S/M,|PARA USO EN TRATAMIENTO DE VIH // LOTE: 24/04/2015 VEN: 31/03/2017|CAJA DE CARTON FOLDCOTE CON 120 TABLETAS RECUBIERTAS EN FRASCO DE POLIETILENO DE ALTA DENS|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S), BATCH: 3039076|REINSCRIPCION DE REGISTRO EN PROCESO, EXP. N¦ 12-071306-1 DEL 24/10/2012 | India | Peru | 3350 |   | | |
| 3004902400 | LOPINAVIR 200 MG + RITONAVIR 50 MG,S/M,S/M,|BATCH:3039852 LT:24/05/2015 VEN:30/04/2017 // BATCH:3039853 LT:26/05/2015 VEN:30/04/2017|CAJA DE CARTON FOLDCOTE CON 120 TABLETAS RECUBIERTAS EN FRASCO DE POLIETILENO DE ALTA DENS|(120`S),PARA USO EN TRATAMIENTO DE VIH // BATCH:3039836 LT:23/05/2015 VEN:30/04/2017|REINSCRIPCION DE REGISTRO EN PROCESO, EXP. N¦ 12-071306-1 DEL 24/10/2012 | India | Peru | 16527 | | | |
| 2933599000 | ESTANDAR DE REFERENCIA S/M MODELO:S/M|USO: CONTROL DE CALIDAD|LOPINAVIR (350 MG)|UNIDADES|1370101 | United States | Peru | 6 | | | |
| 3004201100 | ALUVIA, 120 TABLETAS DE 200MG/50MG | LOPINAVIR/RITONAVIR // ALUVIA // ANTIRETROVIRAL | SIN MODELO | PROTOCOLO: INSIGHT 001 / LOTE Nª LOTE: 175238D | ABBOTT GMBH & CO. KG | United Kingdom | Peru | 50 | | | |
| 3004902400 | RITONAVIR 50 MG + LOPINAVIR 200MG,RITOLOP 250,S/M,|LOTE: E151231, E151231A|FRASCO POR 120 TABLETAS|RITOLOP 250 | India | Peru | 218880 | | | 60 More Columns Available |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 67 | | | |
| 3004902400 | RITONAVIR 50MG+LOPINAVIR 200MG TABL|CONTAINERS (1X120)¦S TABLETS|USO:S/M|LOPINAVIR-RITONAVIR | India | Peru | 3840 | | | |
| 3004902400 | RITONAVIR 50MG+LOPINAVIR 200MG TABL|CONTAINERS (1X120)¦S TABLETS|USO:S/M|LOPINAVIR-RITONAVIR | India | Peru | 6312 | | | |
| 3004902400 | RITONAVIR 50MG+LOPINAVIR 200MG TABL|CONTAINERS (1X120)¦S TABLETS|USO:S/M|LOPINAVIR-RITONAVIR | India | Peru | 389 | | | |
| 3004902400 | RITONAVIR 50MG+LOPINAVIR 200MG TABL|CONTAINERS (1X120)¦S TABLETS|USO:S/M|LOPINAVIR-RITONAVIR | India | Peru | 1094 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S/M|LOTE NO. E170697; VENCE: MAR-2020|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1*120)`S PACKS | India | Peru | 6213 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E170521; VENCE: FEB-20|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1 * 120)`S PACKS | India | Peru | 6216 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E181096; VENCE: ABR-2021|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1 * 120)`S PACKS. ELABORADO POR HETERO LABS LIMITED - INDIA. | India | Peru | 264 | | | |
| 3004902400 | LOPINAVIR & RITONAVIR ORAL SOL, S/M, S/M|LOTE N¦ 4320818023 FAB:08.2018 VALIDO: 01.03.2019|STANDARDS REQUERIDO PARA TESTING DE CALIDAD|STANDARDS RITONAVIR USP API REQUERIDO PARA TESTING EN LA IMPORTACI+N | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR & RITONAVIR ORAL SOL, S/M, S/M|LOTE N¦ LRP-001 FAB: 10.2018 VENCE: 09-2020|LOPINAVIR + RITONAVIR 80MG+20 MG/ML SOLUTION ORAL|LOPINAVIR/RITONAVIR ORAL SOLUTION 80 MG+20 MG /ML X160 ML|ORAL SOLUTION 80 MG+20MG/ML X160ML,(SOLUCI+N ORAL 400 MG+100 MG/5ML X160 ML) | India | Peru | 300 | | | |
| 3004902400 | LOPINAVIR & RITONAVIR ORAL SOL, S/M, S/M|LOTE N¦ 4320818023 FAB: 30.10.18 VENCE: 30.04.19|STANDARDS REQUERIDO PARA TESTING DE CALIDAD|STANDARDS RITONAVIR USP API REQUERIDO PARA TESTING EN LA IMPORTACI+N | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E181158; VENCE: ABR-2021|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1 * 120)`S PACKS. ELABORADO POR HETERO LABS LIMITED - INDIA. | India | Peru | 1992 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E190134; VENCE: DIC-2021|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1 * 120)`S PACKS. ELABORADO POR HETERO LABS LIMITED - INDIA. | India | Peru | 2144 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 4 | | | |
| 3004902400 | LOPINAVIR 200MG+ RITONAVIR 50 MG, KALETRA «, S/M|LOTE N¦ 1083082 FAB:22.04.17 VENCE:31.03.20; 1083083 FAB:23.04.17 VENCE:31.03.20|1083084 FAB:23.04.17 VENCE:31.03.20; 1083085 FAB:23.04.17 VENCE:31.03.20;|LOPINAVIR 200MG+ RITONAVIR 50 MG - COMPRIMIDOS|1083086 FAB:12.05.17 VENCE:30.04.20, ,FABRICADO POR: ABBVIE - ALEMANIA | Germany | Peru | 2449920 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG, S/M, S/M|PARA USO EN TRATAMIENTO DE VIH / SIDA / TABLETAS RECUBIERTAS|CAJA DE CARTON FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) / LOTE: 8091041 F.V: 30/04/2021|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO / EXP: N¦ 12-071306-1 | India | Peru | 3696 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG, S/M, S/M|PARA USO EN TRATAMIENTO DE VIH / SIDA / TABLETAS RECUBIERTAS|CAJA DE CARTON FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) / LOTE: 8087899 F.V: 28/02/2021|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO / EXP: N¦ 12-071306-1 | India | Peru | 5000 | | | |
| 3004902400 | RITOVIR 200MG+50MG , RITOVIR , S-M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO - R.S. EE-06634|RITOVIR (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA) |LOTE: BLK22004A , BLK22005A - MFG.DT.: 03-2020 - EXP. DT.: 02-2023 | India | Peru | 2898 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG, S/M, S/M|PARA USO EN TRATAMIENTO DE VIH / SIDA / TABLETAS RECUBIERTAS|CAJA DE CARTON FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) / LOTE: 8099786 F.V: 30/11/2021|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO / EXP: N¦ 12-071306-1 | India | Peru | 4075 | | | |
| 3004902400 | MEDICAMENTO KALETRA S/M|LOPINAVIR / RITONAVIR|MEDICAMENTO ANTIRETROVIRAL VIH/SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201 KALETRA 80MG LOPINV20MG RITVR LQ BTL-LA, LOTE:1125695, VCTO:01/2022 | United States | Peru | 300 | | | |
| 3004902400 | LOPINAVIR 200MG+RITONAVIR 50MG, RITOVIR, S/M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO // RS EE-06634 / VUCE 2018548845|RITOVIR (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA)|LOTE: BLK2911A,BLK2913A,BLK2915A,BLK2914A // MFG.DT: 10/2019,10/2019 // EXP.DT.: 09/2022 | India | Peru | 5927 | | | |
| 3004902400 | RITOVIR 200MG+50MG, RITOVIR, S/M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO // R.D. N¦ 8820-2018 CON R.S. EE-06634|RITOVIR (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA)|LOTE: BLK22008A,BLK22009A // MFG.DT.: 07/2020 // EXP. DT.: 06/2023 | India | Peru | 2898 | | | |
| 3004902400 | RITOVIR 200MG+50MG, RITOVIR, S/M|FRASCO X 120 TAB // LOTE: BLK2928A,BLK2929A // EXP.DT.: 11/2022|MEDICAMENTOS PARA USO HUMANO // RS EE-06634 / VUCE 2018548845 // MFG.DT: 10/2019,12/2019 /|RITOVIR (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA)|LOTE: BLK2916A,BLK2917A,BLK2925A,BLK2924A/BLK2922A/BLK2921A,BLK2920A,BLK2919A,BLK2918A,BLK | India | Peru | 18018 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E201373A; VENCE: JUN-2023|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETS|PACKING: 1X120`S PACKS. ELABORADO POR HETERO LABS LIMITED - INDIA. | India | Peru | 2406 | | | |
| 2942000000 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N¦ 5090320008 MFG: 04.2020 VALIP UP TO:22.05.2022|PARA CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142778 , 3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 14671 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO - R.D. N¦ 12794-2020 CON R.S. EE-09313|RITOLOP (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA) |LOTE: 21GT103 - MFG.DT.: 03-2021 - EXP. DT.: 02-2023 | India | Peru | 3000 | | | |
| 3004902400 | LOPINAVIR 200 MG+ RITONAVIR 50 MG TABLET , S-M , S-M|LOTE N¦ 3127539 FAB:18.12.2020 VENCE:30.11.2022|LOPINAVIR Y RITONAVIR 200 MG-50 MG TABLETA RECUBIERTA|LOPINAVIR 200 MG+ RITONAVIR 50 MG TABLETS|FABRICADO: MYLAN LABORATORIES LIMITED , LEY N¦ 27450 , QUE EXONERA EL PAGO DE LOS IMPUESTOS | India | Peru | 5760 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO - R.D. N¦ 12794-2020 CON R.S. EE-09313|RITOLOP (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA) |LOTE: 21GT103 - MFG.DT.: 03-2021 - EXP. DT.: 02-2023 - MUESTRA SIN VALOR COMERCIAL | India | Peru | 3 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE: 3139404 F.V: 31-07-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EG-5559 | India | Peru | 12095 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE: 3139406 F.V: 31-08-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EG-5559 | India | Peru | 9384 | | | |
| 3004902400 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N¦ 5090320011 DATE OF ANALYSIS: 01.09.2021 VALIP UP TO: 01.03.2022|PARA CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142778 , 3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 14671 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE: 3139406 F.V: 31-08-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 1152 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR 400MG+ 100MG-5ML , S-M , S-M|LOTE N° LRP-007 FAB: 07.2022 VENCE: 06.2024|SOLUCION ORAL 400MG + 100MG-5ML X 160ML|LOPINAVIR + RITONAVIR 400MG + 100MG-5ML SOLUCION ORAL | United Arab Emirates | Peru | 900 | | | |
| 3004902400 | MEDICAMENTO KALETRA S-M|LOPINAVIR - RITONAVIR|MEDICAMENTO ANTIRETROVIRAL VIH-SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201. KALETRA 80MG LOPINV.20MG RITVR LQ BTL-LA. LOTE:1154572 , VCTO:04-2023. EE-03377 | United States | Peru | 16 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 5 | | | |
| 30049099 | TABS >> RITOLOP 250 499920 TABS 120 S RITONAVIR 50MG + LOPINAVIR 200MG TABS | India | Peru | 4166 | | | |
| 30049099 | MEDICINE >> HARMLESS MEDICINE HARMLESS MEDICINE LOPINAVIR 200MG + RITO | India | Peru | 5903 | | | |
| 30049099 | HARMLESS >> HARMLESS MEDICINE HARMLESS MEDICINE LOPINAVIR 200 MG + RIT | India | Peru | 15380 | | | |
| 30049099 | TABLETS >> HARMLESS MEDICINES LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS 120 S | India | Peru | 3350 | | | |
| 30049099 | TABLETS >> HARMLESS MEDICINES LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS 120 S | India | Peru | 11000 | | | |
| 30049099 | TABLETS >> RITONAVIR TABLETS HARMLESS MEDICINES LOPINAVIR -RITONAVIRTABLETS 200MG-50MG 120 S ; -RITONAVIR TABLETS | India | Peru | 527 | | | |
| 30049099 | TABS >> RITONAVIR 50 MG+LOPINAVIR 200MG TABS | India | Peru | 4166 | | | |
| 30049099 | TABLETS >> TABLETS HDPE LOPINAVIR 200MG+RITONAVIR 50MG TABLETS 1X120'S TABLETS HDPE JAR-PACK ; 1X120'S | India | Peru | 500 | | | |
| 3004902400 | LOPINAVIR AND RITONAVIR ORAL SOLUTION 80MG-20MG PER ML 160ML , KALETRA® , S-M|LOTE N° 1203624 FAB: 17.07.2023 VENCE: 17.07.2025|KALETRA 80MG + 20MG-ML SOLUCION ORAL|KALETRA 80MG LOPINV. 20MG RITVR LIQ BTL-LA|DECRETO SUPREMO N° 023-2016-SA | United States | Peru | 900 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (25 , 000 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT144 , 23GT145 , 23GT146 , 23GT147 , 23GT148 , 23GT149 - MFG.DT.: 07-2023 - EXP. DT.: 06- | India | Peru | 25000 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (50 FRASCO X 120) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT105 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 50 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (100 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT149 - MFG.DT.: 07-2023 - EXP. DT.: 06-2025 | India | Peru | 100 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (10 FRASCO X 120) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT149 - MFG.DT.: 07-2023 - EXP. DT.: 06-2025 | India | Peru | 10 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG BOTTLE X 120 COATED TABLET LOPINAVIR AND RITONAVIR TABLETS USPBATCH NO 23GT149 MANUFACTURING DT 07/2023 | India | Peru | 10 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG BOTTLE X 120 COATED TABLET LOPINAVIR AND RITONAVIR TABLETS USPBATCH NO 23GT105 MANUFACTURING DT 03/2023 | India | Peru | 50 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG BOTTLE X 120 COATED TABLET LOPINAVIR AND RITONAVIR TABLETS USPBATCH NO 23GT149 MANUFACTURING DT 07/2023 | India | Peru | 100 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (10 FRASCO X 120) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT107 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 10 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (8 , 400 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT103 , 23GT106 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 8400 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (16 , 550 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT102 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 16550 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (150 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT107 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 150 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG PACK 120 TabletsFREE SAMPLE FOR PROMOTION, NO COMMERCIAL VALUE LOPINAVIR AND RITONAVIR TABLETS | India | Peru | 10 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG PACK 120 Tablets LOPINAVIR AND RITONAVIR TABLETS USPBATCH NO 23GT107 MANUFACTURING DT 03/2023 EXP DT 0 | India | Peru | 150 | | | |
| 3004902900 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (250 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT102 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 250 | | | |
| 3004902400 | MEDICAMENTO KALETRA S-M|LOPINAVIR 80MG - RITONAVIR 20MG , EE-03377 , RD 3171-2021-DIGEMID DEL 29-03-2021|MEDICAMENTO ANTIRETROVIRAL VIH-SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201 , KALETRA 80MG LOPIN-20MG RITVR LIQ BTL-LA , LOTE:1178144 VCTO:10-2024 | United States | Peru | 102 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 26 | | | |
| 30049024 | LOPINAVIR+RITONAVIR ORAL SOLUTION LOPINAVIR USP 80MG & RITONAVIR USP 20MG PERML 900 BOTTEL | India | Peru | 900 | | | |
| 29420090 | WORKING STANDARDS OF LOPINAVIR USP API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 2942000000 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N° GGG2205002 FAB: 25.11.2022 VENCE: 25.11.2023|PARA USO DE CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR 400MG+100MG-5ML , S-M , S-M|LOTE N° LRP-008 FAB: 12.2022 VENCE: 11.2024|LOPINAVIR + RITONAVIR 80MG+20MG-ML SOLUCION ORAL|LOPINAVIR + RITONAVIR 400MG+100MG-5ML SOLUCION ORAL | India | Peru | 900 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 11 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 5 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 25 | | | |
| 2933599000 | ESTANDAR LOPINAVIR (350 MG) , S-M, S-M|USP. REFERENCE STANDARD|LOTE: R143S0|CODIGO:1370101 | Brazil | Peru | 2 | | | |
| 2933599000 | LOPINAVIR , SIGMA ALDRICH , S-M|PHR1927-1G|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 1G|LOPINAVIR , BATCH: LRAC8605 | China | Peru | 1 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 2 | | | |
| 29420090 | WORKING STANDARDS OF LOPINAVIR USP | India | Peru | 10 | | | |
| 30049024 | LOPINAVIR + RITONAVIR ORAL SOLUTION LOP | India | Peru | 900 | | | |
| 2942000000 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N° GGG2205002 FAB: 04.2022 VENCE: 03.07.2023|PARA USO DEL CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 29420090 | WORKING STANDARDS OF LOPINAVIR USP | India | Peru | 10 | | | |
| 30049024 | LOPINAVIR + RITONAVIR ORAL SOLUTION LOP | India | Peru | 900 | | | |
| 30049024 | LOPINAVIR + RITONAVIR ORAL SOLUTION LOP | India | Peru | 900 | | | |
| 29420090 | WORKING STANDARDS OF LOPINAVIR USP | India | Peru | 10 | | | |
| 3004902400 | MEDICAMENTO KALETRA S-M|LOPINAVIR - RITONAVIR , REG. SANITARIO EE-03377 DEL 13-10-2022 AL 13-10-2025|MEDICAMENTO ANTIRETROVIRAL VIH-SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201. KALETRA 80MG LOPINV.20MG RITVR LQ BTL-LA. LOTE:1162887 , VCTO:02-11-2023 | United States | Peru | 132 | | | |
| 30049099 | LOPINAVIR 200 MG + RITONAVIR 50MG TABLET | India | Peru | 804000 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3152539 F.V: 30-04-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 6700 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3152539 F.V: 30-04-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 6700 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 15 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 3 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 3165 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 3165 | | | |
| 30049099 | MG >> MG TABLE LOPINAVIR 200 MG + RITONAVIR 50 MG TABLE | India | Peru | 379800 | | | |
| 3004902400 | MEDICAMENTO KALETRA S-M|LOPINAVIR - RITONAVIR|MEDICAMENTO ANTIRETROVIRAL VIH-SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201. KALETRA 80MG LOPINV.20MG RITVR LQ BTL-LA. LOTE:1154572 , VCTO:04-2023. EE-03377 | United States | Peru | 16 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142778 , 3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 2652 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142778 , 3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 2652 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR 400MG+ 100MG-5ML , S-M , S-M|LOTE N¦ LRP-006 MFG:11.2021 EXP:10.2023|SOLUCION ORAL 400MG + 100MG-5ML X 160ML|LOPINAVIR + RITONAVIR 400MG + 100MG-5ML SOLUCION ORAL|LEY N¦ 27450 , QUE EXONERA DEL PAGO DEL IMPUESTO GENERAL A LAS VENTAS Y DE LOS , DERECHOS AR | India | Peru | 500 | | | |
| 2942000000 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N¦ 5090320008 MFG: 04.2020 VALIP UP TO:22.05.2022|PARA CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR 400MG+ 100MG-5ML , S-M , S-M|LOTE N¦ LRP-006 MFG:11.2021 EXP:10.2023|SOLUCION ORAL 400MG + 100MG-5ML X 160ML|LOPINAVIR + RITONAVIR 400MG + 100MG-5ML SOLUCION ORAL|LEY N¦ 27450 , QUE EXONERA DEL PAGO DEL IMPUESTO GENERAL A LAS VENTAS Y DE LOS , DERECHOS AR | India | Peru | 500 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|LOTE:3142776 F.V: 31-10-2023 -PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE: 3139406 F.V: 31-08-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 14490 | | |
DownloadHSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
|---|
| 3004902400 | LOPINAVIR 200 MG + RITONAVIR 50 MG,S/M,S/M,|PARA USO EN TRATAMIENTO DE VIH // LOTE: 24/04/2015 VEN: 31/03/2017|CAJA DE CARTON FOLDCOTE CON 120 TABLETAS RECUBIERTAS EN FRASCO DE POLIETILENO DE ALTA DENS|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S), BATCH: 3039076|REINSCRIPCION DE REGISTRO EN PROCESO, EXP. N¦ 12-071306-1 DEL 24/10/2012 | India | Peru | 3350 | | | |
| 3004902400 | LOPINAVIR 200 MG + RITONAVIR 50 MG,S/M,S/M,|BATCH:3039852 LT:24/05/2015 VEN:30/04/2017 // BATCH:3039853 LT:26/05/2015 VEN:30/04/2017|CAJA DE CARTON FOLDCOTE CON 120 TABLETAS RECUBIERTAS EN FRASCO DE POLIETILENO DE ALTA DENS|(120`S),PARA USO EN TRATAMIENTO DE VIH // BATCH:3039836 LT:23/05/2015 VEN:30/04/2017|REINSCRIPCION DE REGISTRO EN PROCESO, EXP. N¦ 12-071306-1 DEL 24/10/2012 | India | Peru | 16527 | | | |
| 2933599000 | ESTANDAR DE REFERENCIA S/M MODELO:S/M|USO: CONTROL DE CALIDAD|LOPINAVIR (350 MG)|UNIDADES|1370101 | United States | Peru | 6 | | | |
| 3004201100 | ALUVIA, 120 TABLETAS DE 200MG/50MG | LOPINAVIR/RITONAVIR // ALUVIA // ANTIRETROVIRAL | SIN MODELO | PROTOCOLO: INSIGHT 001 / LOTE Nª LOTE: 175238D | ABBOTT GMBH & CO. KG | United Kingdom | Peru | 50 | | | |
| 3004902400 | RITONAVIR 50 MG + LOPINAVIR 200MG,RITOLOP 250,S/M,|LOTE: E151231, E151231A|FRASCO POR 120 TABLETAS|RITOLOP 250 | India | Peru | 218880 | | | 60 More Columns Available |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 67 | | | |
| 3004902400 | RITONAVIR 50MG+LOPINAVIR 200MG TABL|CONTAINERS (1X120)¦S TABLETS|USO:S/M|LOPINAVIR-RITONAVIR | India | Peru | 3840 | | | |
| 3004902400 | RITONAVIR 50MG+LOPINAVIR 200MG TABL|CONTAINERS (1X120)¦S TABLETS|USO:S/M|LOPINAVIR-RITONAVIR | India | Peru | 6312 | | | |
| 3004902400 | RITONAVIR 50MG+LOPINAVIR 200MG TABL|CONTAINERS (1X120)¦S TABLETS|USO:S/M|LOPINAVIR-RITONAVIR | India | Peru | 389 | | | |
| 3004902400 | RITONAVIR 50MG+LOPINAVIR 200MG TABL|CONTAINERS (1X120)¦S TABLETS|USO:S/M|LOPINAVIR-RITONAVIR | India | Peru | 1094 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S/M|LOTE NO. E170697; VENCE: MAR-2020|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1*120)`S PACKS | India | Peru | 6213 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E170521; VENCE: FEB-20|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1 * 120)`S PACKS | India | Peru | 6216 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E181096; VENCE: ABR-2021|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1 * 120)`S PACKS. ELABORADO POR HETERO LABS LIMITED - INDIA. | India | Peru | 264 | | | |
| 3004902400 | LOPINAVIR & RITONAVIR ORAL SOL, S/M, S/M|LOTE N¦ 4320818023 FAB:08.2018 VALIDO: 01.03.2019|STANDARDS REQUERIDO PARA TESTING DE CALIDAD|STANDARDS RITONAVIR USP API REQUERIDO PARA TESTING EN LA IMPORTACI+N | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR & RITONAVIR ORAL SOL, S/M, S/M|LOTE N¦ LRP-001 FAB: 10.2018 VENCE: 09-2020|LOPINAVIR + RITONAVIR 80MG+20 MG/ML SOLUTION ORAL|LOPINAVIR/RITONAVIR ORAL SOLUTION 80 MG+20 MG /ML X160 ML|ORAL SOLUTION 80 MG+20MG/ML X160ML,(SOLUCI+N ORAL 400 MG+100 MG/5ML X160 ML) | India | Peru | 300 | | | |
| 3004902400 | LOPINAVIR & RITONAVIR ORAL SOL, S/M, S/M|LOTE N¦ 4320818023 FAB: 30.10.18 VENCE: 30.04.19|STANDARDS REQUERIDO PARA TESTING DE CALIDAD|STANDARDS RITONAVIR USP API REQUERIDO PARA TESTING EN LA IMPORTACI+N | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E181158; VENCE: ABR-2021|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1 * 120)`S PACKS. ELABORADO POR HETERO LABS LIMITED - INDIA. | India | Peru | 1992 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E190134; VENCE: DIC-2021|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETA RECUBIERTA.|PACKING: (1 * 120)`S PACKS. ELABORADO POR HETERO LABS LIMITED - INDIA. | India | Peru | 2144 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 4 | | | |
| 3004902400 | LOPINAVIR 200MG+ RITONAVIR 50 MG, KALETRA «, S/M|LOTE N¦ 1083082 FAB:22.04.17 VENCE:31.03.20; 1083083 FAB:23.04.17 VENCE:31.03.20|1083084 FAB:23.04.17 VENCE:31.03.20; 1083085 FAB:23.04.17 VENCE:31.03.20;|LOPINAVIR 200MG+ RITONAVIR 50 MG - COMPRIMIDOS|1083086 FAB:12.05.17 VENCE:30.04.20, ,FABRICADO POR: ABBVIE - ALEMANIA | Germany | Peru | 2449920 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG, S/M, S/M|PARA USO EN TRATAMIENTO DE VIH / SIDA / TABLETAS RECUBIERTAS|CAJA DE CARTON FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) / LOTE: 8091041 F.V: 30/04/2021|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO / EXP: N¦ 12-071306-1 | India | Peru | 3696 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG, S/M, S/M|PARA USO EN TRATAMIENTO DE VIH / SIDA / TABLETAS RECUBIERTAS|CAJA DE CARTON FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) / LOTE: 8087899 F.V: 28/02/2021|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO / EXP: N¦ 12-071306-1 | India | Peru | 5000 | | | |
| 3004902400 | RITOVIR 200MG+50MG , RITOVIR , S-M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO - R.S. EE-06634|RITOVIR (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA) |LOTE: BLK22004A , BLK22005A - MFG.DT.: 03-2020 - EXP. DT.: 02-2023 | India | Peru | 2898 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG, S/M, S/M|PARA USO EN TRATAMIENTO DE VIH / SIDA / TABLETAS RECUBIERTAS|CAJA DE CARTON FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) / LOTE: 8099786 F.V: 30/11/2021|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO / EXP: N¦ 12-071306-1 | India | Peru | 4075 | | | |
| 3004902400 | MEDICAMENTO KALETRA S/M|LOPINAVIR / RITONAVIR|MEDICAMENTO ANTIRETROVIRAL VIH/SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201 KALETRA 80MG LOPINV20MG RITVR LQ BTL-LA, LOTE:1125695, VCTO:01/2022 | United States | Peru | 300 | | | |
| 3004902400 | LOPINAVIR 200MG+RITONAVIR 50MG, RITOVIR, S/M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO // RS EE-06634 / VUCE 2018548845|RITOVIR (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA)|LOTE: BLK2911A,BLK2913A,BLK2915A,BLK2914A // MFG.DT: 10/2019,10/2019 // EXP.DT.: 09/2022 | India | Peru | 5927 | | | |
| 3004902400 | RITOVIR 200MG+50MG, RITOVIR, S/M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO // R.D. N¦ 8820-2018 CON R.S. EE-06634|RITOVIR (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA)|LOTE: BLK22008A,BLK22009A // MFG.DT.: 07/2020 // EXP. DT.: 06/2023 | India | Peru | 2898 | | | |
| 3004902400 | RITOVIR 200MG+50MG, RITOVIR, S/M|FRASCO X 120 TAB // LOTE: BLK2928A,BLK2929A // EXP.DT.: 11/2022|MEDICAMENTOS PARA USO HUMANO // RS EE-06634 / VUCE 2018548845 // MFG.DT: 10/2019,12/2019 /|RITOVIR (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA)|LOTE: BLK2916A,BLK2917A,BLK2925A,BLK2924A/BLK2922A/BLK2921A,BLK2920A,BLK2919A,BLK2918A,BLK | India | Peru | 18018 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR, LOPINAVIR + RITONAVIR, S-M|LOTE NO. E201373A; VENCE: JUN-2023|MEDICAMENTO ANTIRETROVIRAL PARA EL TRATAMIENTO DEL VIH/SIDA.|LOPINAVIR 200MG + RITONAVIR 50MG TABLETS|PACKING: 1X120`S PACKS. ELABORADO POR HETERO LABS LIMITED - INDIA. | India | Peru | 2406 | | | |
| 2942000000 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N¦ 5090320008 MFG: 04.2020 VALIP UP TO:22.05.2022|PARA CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142778 , 3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 14671 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO - R.D. N¦ 12794-2020 CON R.S. EE-09313|RITOLOP (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA) |LOTE: 21GT103 - MFG.DT.: 03-2021 - EXP. DT.: 02-2023 | India | Peru | 3000 | | | |
| 3004902400 | LOPINAVIR 200 MG+ RITONAVIR 50 MG TABLET , S-M , S-M|LOTE N¦ 3127539 FAB:18.12.2020 VENCE:30.11.2022|LOPINAVIR Y RITONAVIR 200 MG-50 MG TABLETA RECUBIERTA|LOPINAVIR 200 MG+ RITONAVIR 50 MG TABLETS|FABRICADO: MYLAN LABORATORIES LIMITED , LEY N¦ 27450 , QUE EXONERA EL PAGO DE LOS IMPUESTOS | India | Peru | 5760 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 TAB|MEDICAMENTOS PARA USO HUMANO - R.D. N¦ 12794-2020 CON R.S. EE-09313|RITOLOP (LOPINAVIR 200MG+RITONAVIR 50MG TABLETA RECUBIERTA) |LOTE: 21GT103 - MFG.DT.: 03-2021 - EXP. DT.: 02-2023 - MUESTRA SIN VALOR COMERCIAL | India | Peru | 3 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE: 3139404 F.V: 31-07-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EG-5559 | India | Peru | 12095 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE: 3139406 F.V: 31-08-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EG-5559 | India | Peru | 9384 | | | |
| 3004902400 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N¦ 5090320011 DATE OF ANALYSIS: 01.09.2021 VALIP UP TO: 01.03.2022|PARA CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142778 , 3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 14671 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE: 3139406 F.V: 31-08-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 1152 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR 400MG+ 100MG-5ML , S-M , S-M|LOTE N° LRP-007 FAB: 07.2022 VENCE: 06.2024|SOLUCION ORAL 400MG + 100MG-5ML X 160ML|LOPINAVIR + RITONAVIR 400MG + 100MG-5ML SOLUCION ORAL | United Arab Emirates | Peru | 900 | | | |
| 3004902400 | MEDICAMENTO KALETRA S-M|LOPINAVIR - RITONAVIR|MEDICAMENTO ANTIRETROVIRAL VIH-SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201. KALETRA 80MG LOPINV.20MG RITVR LQ BTL-LA. LOTE:1154572 , VCTO:04-2023. EE-03377 | United States | Peru | 16 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 5 | | | |
| 30049099 | TABS >> RITOLOP 250 499920 TABS 120 S RITONAVIR 50MG + LOPINAVIR 200MG TABS | India | Peru | 4166 | | | |
| 30049099 | MEDICINE >> HARMLESS MEDICINE HARMLESS MEDICINE LOPINAVIR 200MG + RITO | India | Peru | 5903 | | | |
| 30049099 | HARMLESS >> HARMLESS MEDICINE HARMLESS MEDICINE LOPINAVIR 200 MG + RIT | India | Peru | 15380 | | | |
| 30049099 | TABLETS >> HARMLESS MEDICINES LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS 120 S | India | Peru | 3350 | | | |
| 30049099 | TABLETS >> HARMLESS MEDICINES LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS 120 S | India | Peru | 11000 | | | |
| 30049099 | TABLETS >> RITONAVIR TABLETS HARMLESS MEDICINES LOPINAVIR -RITONAVIRTABLETS 200MG-50MG 120 S ; -RITONAVIR TABLETS | India | Peru | 527 | | | |
| 30049099 | TABS >> RITONAVIR 50 MG+LOPINAVIR 200MG TABS | India | Peru | 4166 | | | |
| 30049099 | TABLETS >> TABLETS HDPE LOPINAVIR 200MG+RITONAVIR 50MG TABLETS 1X120'S TABLETS HDPE JAR-PACK ; 1X120'S | India | Peru | 500 | | | |
| 3004902400 | LOPINAVIR AND RITONAVIR ORAL SOLUTION 80MG-20MG PER ML 160ML , KALETRA® , S-M|LOTE N° 1203624 FAB: 17.07.2023 VENCE: 17.07.2025|KALETRA 80MG + 20MG-ML SOLUCION ORAL|KALETRA 80MG LOPINV. 20MG RITVR LIQ BTL-LA|DECRETO SUPREMO N° 023-2016-SA | United States | Peru | 900 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (25 , 000 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT144 , 23GT145 , 23GT146 , 23GT147 , 23GT148 , 23GT149 - MFG.DT.: 07-2023 - EXP. DT.: 06- | India | Peru | 25000 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (50 FRASCO X 120) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT105 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 50 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (100 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT149 - MFG.DT.: 07-2023 - EXP. DT.: 06-2025 | India | Peru | 100 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (10 FRASCO X 120) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT149 - MFG.DT.: 07-2023 - EXP. DT.: 06-2025 | India | Peru | 10 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG BOTTLE X 120 COATED TABLET LOPINAVIR AND RITONAVIR TABLETS USPBATCH NO 23GT149 MANUFACTURING DT 07/2023 | India | Peru | 10 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG BOTTLE X 120 COATED TABLET LOPINAVIR AND RITONAVIR TABLETS USPBATCH NO 23GT105 MANUFACTURING DT 03/2023 | India | Peru | 50 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG BOTTLE X 120 COATED TABLET LOPINAVIR AND RITONAVIR TABLETS USPBATCH NO 23GT149 MANUFACTURING DT 07/2023 | India | Peru | 100 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (10 FRASCO X 120) - MUESTRA SIN VALOR COMERCIAL|MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT107 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 10 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (8 , 400 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT103 , 23GT106 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 8400 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (16 , 550 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT102 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 16550 | | | |
| 3004902400 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (150 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP 200 MG+50MG (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT107 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 150 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG PACK 120 TabletsFREE SAMPLE FOR PROMOTION, NO COMMERCIAL VALUE LOPINAVIR AND RITONAVIR TABLETS | India | Peru | 10 | | | |
| 30049099 | RITOLOP 200 MG + 50 MG PACK 120 Tablets LOPINAVIR AND RITONAVIR TABLETS USPBATCH NO 23GT107 MANUFACTURING DT 03/2023 EXP DT 0 | India | Peru | 150 | | | |
| 3004902900 | RITOLOP , RITOLOP , S-M|FRASCO X 120 (250 FRASCO X 120) |MEDICAMENTOS PARA USO HUMANO - R.D. Nº 12794-2020 CON R.S. EE-09313|RITOLOP (LOPINAVIR 200MG+RITONAVIR 50MG) TR , FC X 120 COATED TAB|LOTE: 23GT102 - MFG.DT.: 03-2023 - EXP. DT.: 02-2025 | India | Peru | 250 | | | |
| 3004902400 | MEDICAMENTO KALETRA S-M|LOPINAVIR 80MG - RITONAVIR 20MG , EE-03377 , RD 3171-2021-DIGEMID DEL 29-03-2021|MEDICAMENTO ANTIRETROVIRAL VIH-SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201 , KALETRA 80MG LOPIN-20MG RITVR LIQ BTL-LA , LOTE:1178144 VCTO:10-2024 | United States | Peru | 102 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 26 | | | |
| 30049024 | LOPINAVIR+RITONAVIR ORAL SOLUTION LOPINAVIR USP 80MG & RITONAVIR USP 20MG PERML 900 BOTTEL | India | Peru | 900 | | | |
| 29420090 | WORKING STANDARDS OF LOPINAVIR USP API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 2942000000 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N° GGG2205002 FAB: 25.11.2022 VENCE: 25.11.2023|PARA USO DE CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR 400MG+100MG-5ML , S-M , S-M|LOTE N° LRP-008 FAB: 12.2022 VENCE: 11.2024|LOPINAVIR + RITONAVIR 80MG+20MG-ML SOLUCION ORAL|LOPINAVIR + RITONAVIR 400MG+100MG-5ML SOLUCION ORAL | India | Peru | 900 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 11 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 5 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 25 | | | |
| 2933599000 | ESTANDAR LOPINAVIR (350 MG) , S-M, S-M|USP. REFERENCE STANDARD|LOTE: R143S0|CODIGO:1370101 | Brazil | Peru | 2 | | | |
| 2933599000 | LOPINAVIR , SIGMA ALDRICH , S-M|PHR1927-1G|REACTIVOS PARA LABORATORIO , SÍNTESIS DE SUSTANCIAS , 1 X 1G|LOPINAVIR , BATCH: LRAC8605 | China | Peru | 1 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 2 | | | |
| 29420090 | WORKING STANDARDS OF LOPINAVIR USP | India | Peru | 10 | | | |
| 30049024 | LOPINAVIR + RITONAVIR ORAL SOLUTION LOP | India | Peru | 900 | | | |
| 2942000000 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N° GGG2205002 FAB: 04.2022 VENCE: 03.07.2023|PARA USO DEL CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 29420090 | WORKING STANDARDS OF LOPINAVIR USP | India | Peru | 10 | | | |
| 30049024 | LOPINAVIR + RITONAVIR ORAL SOLUTION LOP | India | Peru | 900 | | | |
| 30049024 | LOPINAVIR + RITONAVIR ORAL SOLUTION LOP | India | Peru | 900 | | | |
| 29420090 | WORKING STANDARDS OF LOPINAVIR USP | India | Peru | 10 | | | |
| 3004902400 | MEDICAMENTO KALETRA S-M|LOPINAVIR - RITONAVIR , REG. SANITARIO EE-03377 DEL 13-10-2022 AL 13-10-2025|MEDICAMENTO ANTIRETROVIRAL VIH-SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201. KALETRA 80MG LOPINV.20MG RITVR LQ BTL-LA. LOTE:1162887 , VCTO:02-11-2023 | United States | Peru | 132 | | | |
| 30049099 | LOPINAVIR 200 MG + RITONAVIR 50MG TABLET | India | Peru | 804000 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3152539 F.V: 30-04-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 6700 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3152539 F.V: 30-04-2024|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 6700 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 15 | | | |
| 30049068 | ALTRETAMINE; BORTEZOMIB; DACARBAZINE; TENOFOVIR DISOPROXIL FUMARATE; ENFUVIRTIDE; FLUSPIRILENE; LETROZOLE; LOPINAVIR; IMATINIB MESYLATE; NELFINAVIR OR ITS MESYLATE; NEVIRAPINE; PEMETREXED; SAQUINAVIR; ABACAVIR SULPHATE; ATAZANAVIR SULPHATE; INDINAVIR SULP | Brazil | Peru | 3 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 3165 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 3165 | | | |
| 30049099 | MG >> MG TABLE LOPINAVIR 200 MG + RITONAVIR 50 MG TABLE | India | Peru | 379800 | | | |
| 3004902400 | MEDICAMENTO KALETRA S-M|LOPINAVIR - RITONAVIR|MEDICAMENTO ANTIRETROVIRAL VIH-SIDA DE CONSUMO HUMANO|KALETRA SOLUCION ORAL - CAJA CON FRASCO X 160ML + VASITO DOSIFICADOR|039562201. KALETRA 80MG LOPINV.20MG RITVR LQ BTL-LA. LOTE:1154572 , VCTO:04-2023. EE-03377 | United States | Peru | 16 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142778 , 3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 2652 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE:3142778 , 3142779 F.V: 31-10-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 2652 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR 400MG+ 100MG-5ML , S-M , S-M|LOTE N¦ LRP-006 MFG:11.2021 EXP:10.2023|SOLUCION ORAL 400MG + 100MG-5ML X 160ML|LOPINAVIR + RITONAVIR 400MG + 100MG-5ML SOLUCION ORAL|LEY N¦ 27450 , QUE EXONERA DEL PAGO DEL IMPUESTO GENERAL A LAS VENTAS Y DE LOS , DERECHOS AR | India | Peru | 500 | | | |
| 2942000000 | WORKING STANDARDS OF LOPINAVIR , S-M , S-M|LOTE N¦ 5090320008 MFG: 04.2020 VALIP UP TO:22.05.2022|PARA CONTROL DE CALIDAD|WORKING STANDARDS OF LOPINAVIR API REQUIRED FOR TESTING BY IMPORTER | India | Peru | 1 | | | |
| 3004902400 | LOPINAVIR + RITONAVIR 400MG+ 100MG-5ML , S-M , S-M|LOTE N¦ LRP-006 MFG:11.2021 EXP:10.2023|SOLUCION ORAL 400MG + 100MG-5ML X 160ML|LOPINAVIR + RITONAVIR 400MG + 100MG-5ML SOLUCION ORAL|LEY N¦ 27450 , QUE EXONERA DEL PAGO DEL IMPUESTO GENERAL A LAS VENTAS Y DE LOS , DERECHOS AR | India | Peru | 500 | | | |
| 3004902400 | LOPINAVIR 200 + RITONAVIR 50MG , S-M , S-M|LOTE:3142776 F.V: 31-10-2023 -PARA USO EN TRATAMIENTO DE VIH - SIDA - TABLETAS RECUBIERTAS|CAJA DE CTN FOLDCOTE X 120 TABLETAS RECUBIERTAS EN FRASCO|LOPINAVIR 200 MG + RITONAVIR 50 MG TABLETS (120`S) - LOTE: 3139406 F.V: 31-08-2023|DE POLIETILENO DE ALTA DENSIDAD COLOR BLANCO - R.S:EE-08052 | India | Peru | 14490 | | |
DownloadMarket research report
Market research report
Frequently asked questions
How to study Peru import market of Lopinavir ?
Volza's data of Peru Lopinavir imports allows you to study detailed data with buyer supplier names for last 10 years.
How to create strategy for Peru Lopinavir imports ?
Volza's data of Peru Lopinavir imports helps you create a import strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
How to find import market intelligence for Lopinavir ?
You can find Peru Lopinavir import market intelligence of last 10 years with buyer, supplier, price and volume from Volza.com
How to new markets for Lopinavir imports ?
You can find New markets for Lopinavir imports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Which Lopinavir products are imported from Peru ?
Major products related with Lopinavir are L Isoleucine, L Tyrosine, B Nad, Dl Phenylalanine, L Valine.
What is the HSN code of Lopinavir ?
Top 5 HSN codes for Lopinavir are HSN Code 3004902400 , HSN Code 30049099, HSN Code 30042099, HSN Code 30049024, HSN Code 30049068, You can check for details at https://www.volza.com/hs-codes.
How authentic is data of Peru Lopinavir imports ?
Volza's data of Peru Lopinavir imports is 100% authentic as it is based on actual import export shipments and is collected globally from over 20,000 ports from over 70+ Countries.
How data of Peru Lopinavir imports can help ?
Data of Peru Lopinavir imports contains strategic information and is very useful for importers and exporters who want to expand global trade, improve supply chain of Lopinavir, find economical vendors, new buyers and fast growing markets.
What information does data of Peru Lopinavir imports contains ?
Data of Peru Lopinavir imports contains date of shipment, Name and contact details of importer, exporter, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
How frequently information on Peru Lopinavir imports is updated ?
We update information of Peru Lopinavir imports every month.
Where does Peru imports Lopinavir from ?
As per the Volza's Peru import data of Lopinavir, India accounted for maximum share with 457 shipments followed by United States with 38 and Brazil at 3rd spot with 38 shipments.
Where can I find latest data of Peru Lopinavir imports ?
You can download latest data of Dec-2023 of Peru Lopinavir imports here
Where can I find data of Peru Lopinavir imports with names of buyers & suppliers ?
You can download Volza Peru Lopinavir import data with names of buyers and suppliers.
What is the subscription cost of information on Peru Lopinavir imports ?
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Whom should I contact with additional questions regarding Peru Lopinavir imports ?
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
2 Ways to avail our services
Online |
|---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
| View More |
Volza Consulting |
|---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
| View More |
Important Links related to Lopinavir imports
Support
Important Links
Partners
Trade Data
Follow Us:
About Us
Partners
Follow Us: